Rituximab and Omalizumab for the Treatment of Bullous Pemphigoid: A Systematic Review of the Literature-Reference-Cited by-同舟云学术

Rituximab and Omalizumab for the Treatment of Bullous Pemphigoid: A Systematic Review of the Literature

Published:2018-11-13 Issue:2 Volume:20 Page:209-216
ISSN:1175-0561
Container-title:American Journal of Clinical Dermatology
language:en
Short-container-title:Am J Clin Dermatol

Author:

Kremer Noa^ORCID,Snast Igor,Cohen Efrat Solomon,Hodak Emmilia,Mimouni Daniel,Lapidoth Moshe,Mazor Sigal,Levi Assi

Publisher

Springer Science and Business Media LLC

Subject

Dermatology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s40257-018-0401-6.pdf

Reference53 articles.

1. Bilgiç Temel A, Bassorgun CI, Akman-Karakaş A, Alpsoy E, Uzun S. Successful treatment of a bullous pemphigoid patient with rituximab who was refractory to corticosteroid and omalizumab treatments. Case Rep Dermatol. 2017;9(1):38–44.

2. Bolognia JL, Jorizzo JL, Rapini RP. Chapter 30 – Pemphigoid Group. In: Bolognia JL, Jorizzo JL, Rapini RP, editors. Dermatology. 3rd ed. Spain: Mosby Elsevier; 2012. p. 475–82.

3. Yu KK, Crew AB, Messingham KAN, Fairley JA, Woodley DT. Omalizumab therapy for bullous pemphigoid. J Am Acad Dermatol. 2014;71:468–74. https://doi.org/10.1016/j.jaad.2014.04.053 .

4. Schmidt E, Seitz CS, Benoit S, Bröcker EB, Goebeler M. Rituximab in autoimmune bullous diseases: mixed responses and adverse effects. Br J Dermatol. 2007;156:352–6. https://doi.org/10.1111/j.1365-2133.2006.07646.x .

5. Feliciani C, Joly P, Jonkman MF, Zambruno G, Zillikens D, Ioannides D, et al. Management of bullous pemphigoid: the European dermatology forum consensus in collaboration with the European academy of dermatology and venereology. Br J Dermatol. 2015;172:867–77. https://doi.org/10.1111/bjd.13717 .

Cited by 100 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Omalizumab and Dupilumab for the Treatment of Bullous Pemphigoid: A Systematic Review;Journal of Clinical Medicine;2024-08-16

2. Targeted therapy for immune mediated skin diseases. What should a dermatologist know?;Anais Brasileiros de Dermatologia;2024-07

3. High serum total IgE levels correlate with urticarial lesions and IgE deposition in perilesional skin of bullous pemphigoid patients: An observational study;Indian Journal of Dermatology, Venereology and Leprology;2024-06-19

4. The pathological function of neutrophils in pemphigoid diseases;Dermatologica Sinica;2024-04

5. Navigating through the challenges of bullous pemphigoid and breast cancer in older adults;Clinical and Experimental Dermatology;2024-03-29